Trial intelligence / Profile preview

Varenicline for Co-occurring Cannabis and Tobacco Use

NCT04595318Phase 4Completed

Sponsor
Albert Einstein College of Medicine
Start
Jan 2015
Primary completion
Jul 2015
Modality
Small Molecules
01

Overview

A Phase 4 trial of varenicline in cannabis use disorder (CUD), tobacco dependence, sponsored by Albert Einstein College of Medicine. Started Jan 2015; status: completed.

02

Drugs

varenicline
03

Conditions

cannabis use disorder (CUD)tobacco dependence

Beyond the preview

Go deeper on NCT04595318.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04595318.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call